{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:38:13Z","timestamp":1780447093360,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,18]]},"DOI":"10.7759\/cureus.39170","type":"journal-article","created":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:35:02Z","timestamp":1684398902000},"source":"Crossref","is-referenced-by-count":1,"title":["Capecitabine May Accelerate Atherosclerosis and Causes Acute Myocardial Infarction in the Left Main Trunk"],"prefix":"10.7759","author":[{"given":"Tetsuo","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutarou","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimaro","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Fukatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043116","article-title":"Capecitabine as adjuvant treatment for stage III colon cancer","volume":"352","author":"Twelves C","year":"2005","unstructured":"Twelves C, Wong A, Nowacki MP, et al.. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med. 2005, 352:2696-704. 10.1056\/NEJMoa043116","journal-title":"N Engl J Med"},{"key":"ref2","article-title":"Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible","volume":"125","author":"G\u00fcven\u00e7 TS","year":"2012","unstructured":"G\u00fcven\u00e7 TS, Celiker E, Ozcan KS, Ilhan E, Eren M. Acute myocardial infarction after capecitabine treatment: not always vasospasm is responsible. Chin Med J (Engl). 2012, 125:3349-51.","journal-title":"Chin Med J (Engl)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk A","year":"2013","unstructured":"Polk A, Vaage-Nilsen M, Vistisen K, Nielsen DL. Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors. Cancer Treat Rev. 2013, 39:974-84. 10.1016\/j.ctrv.2013.03.005","journal-title":"Cancer Treat Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s0828-282x(06)70905-9","article-title":"Acute coronary syndrome induced by oral capecitabine","volume":"22","author":"Cardinale D","year":"2006","unstructured":"Cardinale D, Colombo A, Colombo N. Acute coronary syndrome induced by oral capecitabine. Can J Cardiol. 2006, 22:251-3. 10.1016\/s0828-282x(06)70905-9","journal-title":"Can J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.06.152","article-title":"Capecitabine induced vasospastic angina","volume":"130","author":"Coughlin S","year":"2008","unstructured":"Coughlin S, Das S, Lee J, Cooper J. Capecitabine induced vasospastic angina. Int J Cardiol. 2008, 130:e34-6. 10.1016\/j.ijcard.2007.06.152","journal-title":"Int J Cardiol"},{"key":"ref6","article-title":"Capecitabine may induce coronary artery vasospasm","volume":"52","author":"Tsiamis E","year":"2011","unstructured":"Tsiamis E, Synetos A, Stefanadis C. Capecitabine may induce coronary artery vasospasm. Hellenic J Cardiol. 2011, 52:320-3.","journal-title":"Hellenic J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf035","article-title":"Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil","volume":"13","author":"Frickhofen N","year":"2002","unstructured":"Frickhofen N, Beck FJ, Jung B, Fuhr HG, Andrasch H, Sigmund M. Capecitabine can induce acute coronary syndrome similar to 5-fluorouracil. Ann Oncol. 2002, 13:797-801. 10.1093\/annonc\/mdf035","journal-title":"Ann Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1023\/a:1011152931300","article-title":"Coronary spasm induced by capecitabine","volume":"12","author":"Schnetzler B","year":"2001","unstructured":"Schnetzler B, Popova N, Collao Lamb C, Sappino AP. Coronary spasm induced by capecitabine. Ann Oncol. 2001, 12:723-4. 10.1023\/a:1011152931300","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000450544","article-title":"Capecitabine-induced coronary vasospasm","volume":"9","author":"Henry D","year":"2016","unstructured":"Henry D, Rudzik F, Butts A, Mathew A. Capecitabine-induced coronary vasospasm. Case Rep Oncol. 2016, 9:629-32. 10.1159\/000450544","journal-title":"Case Rep Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2459\/01.JCM.0000199785.94760.50","article-title":"Coronary artery spasm induced by capecitabine","volume":"7","author":"Sestito A","year":"2006","unstructured":"Sestito A, Sgueglia GA, Pozzo C, Cassano A, Barone C, Crea F, Lanza GA. Coronary artery spasm induced by capecitabine. J Cardiovasc Med (Hagerstown). 2006, 7:136-8. 10.2459\/01.JCM.0000199785.94760.50","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/000331970405500114","article-title":"Capecitabine-induced coronary vasospasm--a case report","volume":"55","author":"Rizvi AA","year":"2004","unstructured":"Rizvi AA, Schauer P, Owlia D, Kallal JE. Capecitabine-induced coronary vasospasm--a case report. Angiology. 2004, 55:93-7. 10.1177\/000331970405500114","journal-title":"Angiology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2006.03.010","article-title":"Acute coronary syndrome induced by capecitabine therapy","volume":"15","author":"Wijesinghe N","year":"2006","unstructured":"Wijesinghe N, Thompson PI, McAlister H. Acute coronary syndrome induced by capecitabine therapy. Heart Lung Circ. 2006, 15:337-9. 10.1016\/j.hlc.2006.03.010","journal-title":"Heart Lung Circ"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2459\/JCM.0b013e32832bb9b1","article-title":"Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report","volume":"10","author":"Farina A","year":"2009","unstructured":"Farina A, Malafronte C, Valsecchi MA, Achilli F. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report. J Cardiovasc Med (Hagerstown). 2009, 10:722-6. 10.2459\/JCM.0b013e32832bb9b1","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1078155211399164","article-title":"Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm","volume":"18","author":"Shah NR","year":"2012","unstructured":"Shah NR, Shah A, Rather A. Ventricular fibrillation as a likely consequence of capecitabine-induced coronary vasospasm. J Oncol Pharm Pract. 2012, 18:132-5. 10.1177\/1078155211399164","journal-title":"J Oncol Pharm Pract"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-6-200403160-00034","article-title":"Capecitabine induces severe angina-like chest pain","volume":"140","author":"Kuppens IE","year":"2004","unstructured":"Kuppens IE, Boot H, Beijnen JH, Schellens JH, Labadie J. Capecitabine induces severe angina-like chest pain. Ann Intern Med. 2004, 140:494-5. 10.7326\/0003-4819-140-6-200403160-00034","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby J","year":"2014","unstructured":"Crosby J, Peloso GM, Auer PL, et al.. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014, 371:22-31. 10.1056\/NEJMoa1307095","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk\u00a0of\u00a0cardiovascular disease and aortic\u00a0stenosis","volume":"71","author":"Tsimikas S","year":"2018","unstructured":"Tsimikas S, Fazio S, Ferdinand KC, et al.. NHLBI working group recommendations to reduce lipoprotein(a)-mediated risk\u00a0of\u00a0cardiovascular disease and aortic\u00a0stenosis. J Am Coll Cardiol. 2018, 71:177-92. 10.1016\/j.jacc.2017.11.014","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0702593","article-title":"Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor","volume":"127","author":"Zouki C","year":"1999","unstructured":"Zouki C, Baron C, Fournier A, Filep JG. Endothelin-1 enhances neutrophil adhesion to human coronary artery endothelial cells: role of ET(A) receptors and platelet-activating factor. Br J Pharmacol. 1999, 127:969-79. 10.1038\/sj.bjp.0702593","journal-title":"Br J Pharmacol"},{"key":"ref19","article-title":"Endothelin-1 and 5-fluorouracil-induced cardiotoxicity","volume":"45","author":"Porta C","year":"1998","unstructured":"Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma. 1998, 45:81-2.","journal-title":"Neoplasma"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH699>3.0.CO;2-9","article-title":"Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis","volume":"192","author":"Boyle JJ","year":"2000","unstructured":"Boyle JJ, Wilson B, Bicknell R, Harrower S, Weissberg PL, Fan TP. Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis. J Pathol. 2000, 192:234-42.","journal-title":"J Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/155720-capecitabine-may-accelerate-atherosclerosis-and-causes-acute-myocardial-infarction-in-the-left-main-trunk","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:49Z","timestamp":1707508909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/155720-capecitabine-may-accelerate-atherosclerosis-and-causes-acute-myocardial-infarction-in-the-left-main-trunk"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.39170","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,18]]}}}